P A L Seghers, Shabbir M H Alibhai, Nicolò Matteo Luca Battisti, Ravindran Kanesvaran, Martine Extermann, Anita O'Donovan, Sophie Pilleron, Anna Rachelle Mislang, Najia Musolino, Kwok-Leung Cheung, Anthony Staines, Charis Girvalaki, Pierre Soubeyran, Johanneke E A Portielje, Siri Rostoft, Marije E Hamaker, Dominic Trépel, Shane O'Hanlon
{"title":"Geriatric assessment for older people with cancer: policy recommendations.","authors":"P A L Seghers, Shabbir M H Alibhai, Nicolò Matteo Luca Battisti, Ravindran Kanesvaran, Martine Extermann, Anita O'Donovan, Sophie Pilleron, Anna Rachelle Mislang, Najia Musolino, Kwok-Leung Cheung, Anthony Staines, Charis Girvalaki, Pierre Soubeyran, Johanneke E A Portielje, Siri Rostoft, Marije E Hamaker, Dominic Trépel, Shane O'Hanlon","doi":"10.1186/s41256-023-00323-0","DOIUrl":null,"url":null,"abstract":"<p><p>Most cancers occur in older people and the burden in this age group is increasing. Over the past two decades the evidence on how best to treat this population has increased rapidly. However, implementation of new best practices has been slow and needs involvement of policymakers. This perspective paper explains why older people with cancer have different needs than the wider population. An overview is given of the recommended approach for older people with cancer and its benefits on clinical outcomes and cost-effectiveness. In older patients, the geriatric assessment (GA) is the gold standard to measure level of fitness and to determine treatment tolerability. The GA, with multiple domains of physical health, functional status, psychological health and socio-environmental factors, prevents initiation of inappropriate oncologic treatment and recommends geriatric interventions to optimize the patient's general health and thus resilience for receiving treatments. Multiple studies have proven its benefits such as reduced toxicity, better quality of life, better patient-centred communication and lower healthcare use. Although GA might require investment of time and resources, this is relatively small compared to the improved outcomes, possible cost-savings and compared to the large cost of oncologic treatments as a whole.</p>","PeriodicalId":52405,"journal":{"name":"Global Health Research and Policy","volume":"8 1","pages":"37"},"PeriodicalIF":4.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472678/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Health Research and Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s41256-023-00323-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Most cancers occur in older people and the burden in this age group is increasing. Over the past two decades the evidence on how best to treat this population has increased rapidly. However, implementation of new best practices has been slow and needs involvement of policymakers. This perspective paper explains why older people with cancer have different needs than the wider population. An overview is given of the recommended approach for older people with cancer and its benefits on clinical outcomes and cost-effectiveness. In older patients, the geriatric assessment (GA) is the gold standard to measure level of fitness and to determine treatment tolerability. The GA, with multiple domains of physical health, functional status, psychological health and socio-environmental factors, prevents initiation of inappropriate oncologic treatment and recommends geriatric interventions to optimize the patient's general health and thus resilience for receiving treatments. Multiple studies have proven its benefits such as reduced toxicity, better quality of life, better patient-centred communication and lower healthcare use. Although GA might require investment of time and resources, this is relatively small compared to the improved outcomes, possible cost-savings and compared to the large cost of oncologic treatments as a whole.
期刊介绍:
Global Health Research and Policy, an open-access, multidisciplinary journal, publishes research on various aspects of global health, addressing topics like health equity, health systems and policy, social determinants of health, disease burden, population health, and other urgent global health issues. It serves as a forum for high-quality research focused on regional and global health improvement, emphasizing solutions for health equity.